...
首页> 外文期刊>American Journal of Ophthalmology: The International Journal of Ophthalmology >Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
【24h】

Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.

机译:增生性糖尿病视网膜病变患者的玻璃体内血管内皮生长因子和低氧诱导因子1a。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To determine vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1a (HIF-1a) in the vitreous fluid of patients with proliferative diabetic retinopathy (PDR). DESIGN: Observational case-control study. METHODS: Serum and vitreous fluid samples were obtained during vitrectomy from 42 eyes of diabetic patients with PDR (17 type I and 25 type II diabetes mellitus) and from 23 eyes of nondiabetic patients. Retinopathy of 19 diabetic patients was graded as active and the other 23 graded as quiescent according to retinal neovascularization. VEGF and HIF-1a of serum and vitreous fluid samples were measured by enzyme-linked immunosorbent assay. RESULTS: Both intravitreous VEGF and HIF-1a were higher in diabetic patients with PDR than in control subjects (P < .01 and P < .01, respectively). After adjusting for total intravitreous protein (TP) concentration, intravitreous VEGF/TP and HIF-1a/TP in diabetic patients remained significantly higher too. Correlations between intravitreous VEGF and HIF-1a and intravitreous VEGF/TP and HIF-1a/TP were observed in diabetic patients with PDR (r = 0.730; P < .01; r = 0.531; P < .01, respectively) but not in control subjects. Both intravitreous VEGF and HIF-1a were higher in diabetic patients with active PDR than in those with quiescent PDR (P < .01 and P < .05, respectively). Intravitreous VEGF/TP in patients with active PDR remained higher (P < .05). Correlation between intravitreous VEGF and HIF-1a, as well as correlation between intravitreous VEGF/TP and HIF-1a/TP, were observed in diabetic patients with active PDR and those with quiescent PDR but not observed in control subjects. CONCLUSIONS: Intravitreous VEGF and HIF-1a in diabetic patients with PDR are increased and related mutually. VEGF and HIF-1a, especially VEGF, are associated with the angiogenesis of PDR.
机译:目的:测定增生性糖尿病视网膜病变(PDR)患者玻璃体液中的血管内皮生长因子(VEGF)和缺氧诱导因子1a(HIF-1a)。设计:观察病例对照研究。方法:在玻璃体切除术中,从42例PDR糖尿病患者(17例I型和25例II型糖尿病)和23例非糖尿病患者的血清中获取玻璃体液。根据视网膜新血管形成,将19例糖尿病患者的视网膜病变定为活动性,将其他23例定为静止。通过酶联免疫吸附法测定血清和玻璃体液中的VEGF和HIF-1a。结果:糖尿病PDR患者的玻璃体内VEGF和HIF-1a均高于对照组(分别为P <.01和P <.01)。调整总玻璃体内蛋白(TP)浓度后,糖尿病患者的玻璃体内VEGF / TP和HIF-1a / TP仍显着升高。在患有PDR的糖尿病患者中观察到玻璃体内VEGF和HIF-1a与玻璃体内VEGF / TP和HIF-1a / TP之间的相关性(分别为r = 0.730; P <.01; r ​​= 0.531; P <.01),而在PDR中则没有。控制对象。活动性PDR的糖尿病患者的玻璃体内VEGF和HIF-1a均高于静止性PDR的糖尿病患者(分别为P <.01和P <.05)。活动性PDR患者的玻璃体内VEGF / TP仍然较高(P <.05)。在活动性PDR和静止性PDR的糖尿病患者中观察到玻璃体内VEGF和HIF-1a之间的相关性,以及玻璃体内VEGF / TP和HIF-1a / TP之间的相关性,但在对照受试者中未观察到。结论:糖尿病PDR患者玻璃体内VEGF和HIF-1a升高,且相互关联。 VEGF和HIF-1a,特别是VEGF,与PDR的血管生成有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号